FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Verona Gets Ohtuvayre Approval for COPD

FDA approves a Verona Pharma NDA for Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult p...

latest-news-card-1
Human Drugs

BrainStorm Gets FDA Alignment on CMC Issues

BrainStorm Cell Therapeutics says it has reached alignment with FDA on chemistry, manufacturing, and controls aspects of the companys upcoming Phase 3...

latest-news-card-1
Medical Devices

CDRH Joins Gates Foundation on Analytic Methods

CDRH says it is partnering with the Bill and Melinda Gates Foundation and the National Institute for Standards and Technology on a project to develop ...

latest-news-card-1
Federal Register

Info Collection on Device TAP Pilot

Federal Register notice: FDA submits to OMB a proposed information collection entitled Voluntary Total Product Life Cycle (TPLC) Advisory Program (TAP...

latest-news-card-1
Federal Register

Comments Sought on IT and Customer Strategy

Federal Register notice: FDA requests comments on its Information Technology Strategy and Customer Experience Strategy.

latest-news-card-1
Medical Devices

Tempus AI Device for Atrial Fibrillation

FDA clears a Tempus AI 510(k) for its Tempus ECG-AF device that uses artificial intelligence to help identify patients at increased risk of atrial fib...

Medical Devices

Fujifilm New CT System Cleared

FDA clears a Fujifilm Healthcare Americas 510(k) for its new compact, 128-slice computed tomography (CT) system, the FCT iStream.

latest-news-card-1
FDA General

Public Citizen Ideas to Improve Advisory Committees

Public Citizen recommends three steps FDA should take to improve the public perception and understanding of the work of agency advisory committees.

latest-news-card-1
Human Drugs

14 Submissions with RWE in FY 2023: FDA

FDA publishes a table with information on 14 drug submissions in FY 2023 that contained real-world evidence.

latest-news-card-1
Human Drugs

Sani-Care Salon Products CGMP Violations

FDA warns Cartersville, GA-based Sani-Care Salon Products about CGMP violations in its work as a contract manufacturer of finished drugs.